Evolutionary Genomics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$1,854,297 over the previous period. Total operating expenses were $2,014,302.

Profit Margin

Evolutionary Genomics, Inc. (OTC:FNAM): Profit margin
2013 0 -19.26K
2014 348.03K -27.13K -7.8%
2015 262.92K -285.99K -108.78%
2016 221.58K -1.15M -519.91%
2017 32.69K -539.61K -1650.71%
2018 114.81K -1.09M -956.87%
2019 122.68K -793.14K -646.48%
2020 12.5K -1.71M -13695.06%
2021 0 -2.70M
2022 0 -1.85M

FNAM Income Statement (2013 – 2022)

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue
Revenue
0012.5K122.68K114.81K32.69K221.58K262.92K348.03K0
Cost of revenue
1.02M1.03M1.79K205.82K000146.57K24.50K0
Gross profit
-1.02M-1.03M10.70K-83.14K114.81K32.69K221.58K116.34K323.52K0
Operating exp.
Research and development
417.45K1.23M1.79M472.61K473.99K791.06K719.9K416.16K115.72K0
Selling and marketing
0000000000
Total operating expenses
2.01M2.87M2.89M897.51K951.61K1.33M1.27M839.20K24.46K14.50K
Operating income
-2.01M-2.87M-2.87M-774.82K-836.79K-1.30M-1.05M-722.85K-24.50K-14.55K
Other income (expenses), net
79.33K83.99K180.55K13.59K-261.81K232.77K-98.55K436.85K963.27K-48
Income before tax
-1.93M-2.79M-2.69M-761.23K-1.09M-1.06M-1.15M-285.99K-27.13K-19.26K
Income tax expense
-80.67K-83.99K-987.35K31.90K-261.81K-530.23K98.55K-483.52K2.59K4.65K
Net income
-1.85M-2.70M-1.71M-793.14K-1.09M-539.61K-1.15M-285.99K-27.13K-19.26K
Earnings per share
Basic EPS
-0.29-0.46-0.29-0.13-0.19-0.09-0.2-0.05-0.00-0.15
Diluted EPS
-0.29-0.46-0.29-0.13-0.19-0.09-0.2-0.05-0.00-0.15
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source